327 related articles for article (PubMed ID: 37759525)
1. Multiple Roles of the RUNX Gene Family in Hepatocellular Carcinoma and Their Potential Clinical Implications.
Krajnović M; Kožik B; Božović A; Jovanović-Ćupić S
Cells; 2023 Sep; 12(18):. PubMed ID: 37759525
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and immune characteristics of RUNX gene family in human cancers: a pan-cancer analysis.
Zhao H; Chen Y; Shen P; Gong L
Aging (Albany NY); 2022 May; 14(9):4014-4035. PubMed ID: 35522574
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis.
Miyagawa K; Sakakura C; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Ida H; Yazumi S; Chiba T; Ito Y; Hagiwara A
Anticancer Res; 2006; 26(5B):3633-43. PubMed ID: 17094378
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target.
Hung CH; Chiu YC; Chen CH; Hu TH
Biomed Res Int; 2014; 2014():486407. PubMed ID: 24800233
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs involved with hepatocellular carcinoma (Review).
Mao B; Wang G
Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
[TBL] [Abstract][Full Text] [Related]
6. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
Chen E; Xu X; Liu R; Liu T
Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
[TBL] [Abstract][Full Text] [Related]
7. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA network: Novel insight into hepatocellular carcinoma metastasis (Review).
Zhu X; Pan H; Liu L
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34013360
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the landscape of gene cooperativity with receptor tyrosine kinases in liver tumorigenesis using transposon-mediated mutagenesis.
Fan Y; Bazai SK; Daian F; Arechederra M; Richelme S; Temiz NA; Yim A; Habermann BH; Dono R; Largaespada DA; Maina F
J Hepatol; 2019 Mar; 70(3):470-482. PubMed ID: 30529386
[TBL] [Abstract][Full Text] [Related]
10. S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development.
Sobolewski C; Abegg D; Berthou F; Dolicka D; Calo N; Sempoux C; Fournier M; Maeder C; Ay AS; Clavien PA; Humar B; Dufour JF; Adibekian A; Foti M
Gut; 2020 Oct; 69(10):1841-1854. PubMed ID: 31919231
[TBL] [Abstract][Full Text] [Related]
11. The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.
Karbasforooshan H; Hayes AW; Mohammadzadeh N; Zirak MR; Karimi G
Cell Cycle; 2020 Dec; 19(23):3209-3221. PubMed ID: 33164623
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
13. Molecular classification of hepatocellular carcinoma.
Zucman-Rossi J
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S235-41. PubMed ID: 20547309
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
15. Early molecular and genetic determinants of primary liver malignancy.
Feitelson MA; Pan J; Lian Z
Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.
Chen L; Chan TH; Guan XY
Acta Pharmacol Sin; 2010 Sep; 31(9):1165-71. PubMed ID: 20676120
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of hepatocellular carcinoma.
Moradpour D; Blum HE
Eur J Gastroenterol Hepatol; 2005 May; 17(5):477-83. PubMed ID: 15827436
[TBL] [Abstract][Full Text] [Related]
18. The RUNX Family of Proteins, DNA Repair, and Cancer.
Krishnan V
Cells; 2023 Apr; 12(8):. PubMed ID: 37190015
[TBL] [Abstract][Full Text] [Related]
19. NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
Emma MR; Iovanna JL; Bachvarov D; Puleio R; Loria GR; Augello G; Candido S; Libra M; Gulino A; Cancila V; McCubrey JA; Montalto G; Cervello M
Cell Death Dis; 2016 Jun; 7(6):e2269. PubMed ID: 27336713
[TBL] [Abstract][Full Text] [Related]
20. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
Zhang Y
Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
